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Block abstract  
We investigated characteristics, causes and treatment of postpartum haemorrhage 
(PPH) in a random sample of 294 women’s first and second pregnancies involving at 
least one PPH. Among 588 pregnancies, PPH affected 169 first pregnancies, 105 second 
pregnancies only and recurrent PPH affected 48 pregnancies. In 34% of PPHs, atony 
was the primary cause. Second pregnancy PPH involved increased pharmacological 
therapy, blood transfusion and median blood loss. It is important to ascertain PPH 
history in parous women and be prepared for PPH recurrence. 
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Introduction 
Postpartum haemorrhage (PPH) is one of the leading causes of maternal morbidity and 
mortality.  Recent research indicates that the incidence of postpartum haemorrhage 
and associated adverse outcomes in developed countries are increasing.[1],[2]  
Canadian and US studies suggest that such increases are driven by increases in uterine 
atony which is purported to be the cause of three-quarters of postpartum 
haemorrhages in high resource settings.[3 4] However, the accuracy of reporting of the 
cause of PPH has been questioned.[5] 
Nulliparity and grand multiparity (≥5 births) have been demonstrated to be risk factors 
for PPH,[3 6 7] however where PPH occurs in a second pregnancy it is not known 
whether the aetiology and treatment differs from that in a first pregnancy. 
Furthermore, among women having a PPH, it is not clear whether a subsequent PPH 
involves more severe bleeding.  The aim of this study was to investigate the 
characteristics, causes and treatment of PPH in first and second pregnancies. 
 
Methods 
We utilised data collected in a review of PPH among 294 women with first and second 
pregnancies (representing 588 pregnancy records) and at least one PPH. The details of 
this study are reported elsewhere.[5] Briefly, we selected a random sample of 600 first 
and second birth medical records for 300 women giving birth in New South Wales 
(2002-2006) where hospital data reported a PPH after either or both pregnancies.  
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Data were abstracted from delivery summaries, progress notes, operation and 
anaesthetic charts in medical records.  
 
Postpartum haemorrhage was defined as blood loss of ≥ 500 mL following vaginal birth 
or ≥ 750 mL following caesarean section (ICD-10AM blood loss criteria)[8] or where a 
diagnosis of PPH was recorded in the medical record.  Up to two causes of PPH could 
be identified in the abstracted data, with a primary cause identified where possible. No 
cause could be ascertained for 80 (24.8%) PPHs. Prophylactic oxytocin was recorded as 
part of active management of labour. Therapeutic pharmacological treatment included 
oxytocin or other pharmacological treatment initiated after bleeding to control blood 
loss.   
 
Contingency table analyses are presented, with chi-square analyses used to report 
statistical significance at the P < 0.05 (two-tailed) level. Since blood loss data had a 
skewed distribution,  medians  are reported . Differences in blood loss were assessed 
with Wilcoxon Mann-Whitney tests and Wilcoxon signed rank sum tests. Ethics 
approval was granted by the NSW Population and Health Services Human Research 
Ethics Committee (HREC), the Northern Sydney Central Coast Area Health Service 
HREC, and individual ethics or patient care review committees. 
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Results 
Of the 588 (294 first, 294 second) pregnancies, the majority were singleton births 
(98.3%) in public hospitals (81.3%).  Three hundred and twenty-two births were 
followed by a PPH during the birth admission. Of 322 records with a PPH, 251 (78.0%) 
had a clinical diagnosis and 71 (22.0%) met the blood loss criteria lone..  Severe PPH 
(≥1000mL) occurred in 91 PPHs (28.3%).  
One hundred and twenty one women had only a first pregnancy PPH, 105 women had 
only a second pregnancy PPH and 48 women (16.3%) had a PPH after both 
pregnancies. This represents a recurrence rate of 28.4%. The median blood loss at first 
pregnancy PPH was 700 mLs (range 200-2800) and at second pregnancy PPH 
(irrespective of haemorrhage history) was 800 mLs (range 200-4000; P=0.08).  Forty 
percent (40.4%; N=19) of women having a recurrent PPH lost ≥1000mLs following their 
second PPH and for three-quarters of these women (74%; n=14) their second 
haemorrhage was more severe than their earlier haemorrhage (p=0.21).  
 
Births in which a PPH occurred had the following characteristics (compared to non-PPH 
births): higher proportions of multiple births (2.8% vs 0.4%, P=0.03), primparous births 
(53.4% vs 46.6%), vaginal births (76.1% vs 65.8%, P=0.01), second stage of labour of ≥1 
hour (among births with labour; 40.5% vs 32.2%), and obstructed labour (29.5% vs 
18.2%, P=0.002). Most PPHs (91.7%) occurred within 1-2 hours of birth.  
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The most common primary cause of PPH at a first or second postpartum haemorrhage 
was uterine atony (35.5% and 32.0% of PPHs respectively). Atony and laceration 
(15.7% vs  9.3%) were more frequently identified as the primary cause at first PPH 
(compared to second PPH), whereas retained placenta (15.7% vs 18.7%) and placenta 
accreta/ increta/ percreta (1.2% vs 2.7%) were more common among second PPHs. 
However, differences were not statistically significant. The causes associated with the 
largest blood loss (≥1000mLs) were atony (first and second pregnancy PPH), and 
retained placenta (second PPH). Forty-four (44.4) percent of women with a first PPH 
related to uterine atony, went on to have a subsequent PPH with the same attributed 
cause, however this represented 8 out of 18 women. For other causes there was little 
correlation between the two pregnancies.  
 
Ninety-one percent (91.4%) of PPHs that occurred after a vaginal delivery had evidence 
of active management of the third stage of labour. Oxytocin treatment at therapeutic 
doses followed third stage prophylactic oxytocic administration in 47% (range 33%-
89% across hospitals) of PPHs post vaginal delivery, however there was variable 
recording of prophylaxis by hospitals with 2 hospitals not recording third stage 
prophylactic oxytocic use. 
 
A higher proportion of second pregnancy PPHs were given pharmacological treatment, 
in particular an oxytocin infusion or bolus, than those occurring following a first 
pregnancy (Table 1). Similarly a higher proportion of manual removal of the placenta 
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and transfusions were performed following second pregnancy PPHs (Table 1). There 
were no uterine arterial ligations, embolisations, B-lynch sutures or hysterectomies 
documented in the study population. Among women with a recurrent PPH, 91% had 
pharmacological treatment of both haemorrhages. A blood or blood component 
transfusion was initiated following 31 (7.7%) PPHs. There were 2 transfusions recorded 
following pregnancies that were not recorded as having PPHs but which involved a 
haematoma and intra-peritoneal bleeding.   
 
Discussion 
Findings of this study indicate that the role of uterine atony as a primary cause of PPH 
may be over-estimated in some studies, that there are often multiple causes of PPH 
present and that PPH in subsequent pregnancies may potentially be more severe than 
a first PPH.  
 
In our study, approximately one in three PPHs were primarily related to uterine atony, 
a lower proportion than reported in the USA or Canada where reporting is based on 
ICD coding,[3 4] but similar to that reported in France and Scotland.[9 10] Importantly, 
the non-specific ICD code for atony includes genital tract trauma[1] and our results 
indicate a likely over-estimation of atony based on use of this ICD code. In one quarter 
of pregnancies with a PPH in our study there were multiple causes present. This 
demonstrates the complexity in many cases of identifying the course of events 
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culminating in haemorrhage.  We are not aware of other research that has 
investigated PPH  cause in pregnancies with a history of PPH. Data from this study 
indicates that apart from atony, there was little correlation between PPH cause in 
subsequent pregnancies.  
 
With one in three women having a recurrent PPH, awareness of both the fact and the 
precipitating cause of a prior haemorrhage should signal the need for preparedness in 
a subsequent pregnancy. The UK Royal College of Obstetricians and Gynaecologists 
recommend that for women presenting antenatally with a history of PPH, this history 
should be taken into account when discussing the setting for delivery.[11]  Several 
studies have demonstrated that a prior haemorrhage increases the risk of a 
subsequent haemorrhage.[6 12 13] Our study demonstrated that for the majority of 
women having a subsequent haemorrhage (74%), the second haemorrhage involved 
larger blood loss. However, probably due to small numbers, this did not translate into 
a statistically significant difference in blood loss. In addition, the role of PPH 
prophylaxis should be discussed including active management of the third stage of 
labour, additional uterotonics, crossmatching and intravenous access. Screening for 
and treating iron deficiency anaemia, and ensuring timely access to an operating 
theatre if required are other strategies that can be used to limit the effect and amount 
of PPH.  
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The increased use of pharmacological therapy, higher median blood loss and trend 
towards increased transfusion among recurrent PPHs (compared to first pregnancy 
PPHs) may indicate a more severe PPH at second pregnancy. Increased proportions of 
pharmacological therapy and transfusion (whether or not a prior postpartum 
haemorrhage occurred) may also indicate a lower threshold to intervention in a 
second pregnancy.  
 
Strengths of the study include the ability to investigate blood loss at subsequent 
pregnancies. The restriction to review of birth admission records means some 
secondary PPHs requiring readmission may have been missed. It is possible that the 
amount of blood loss is under-recorded since in many hospitals it is primarily based on 
visual estimation. [14] 
 
Conclusion 
Uterine atony remains a leading cause of primary PPH and there is some indication 
that a subsequent haemorrhage may also involve atony. Importantly, our study found 
a trend towards increased blood loss at a subsequent haemorrhage. These results 
highlight the importance of ascertaining pregnancy history in parous women and the 
need for prevention and preparedness for what is often an unexpected obstetric 
emergency for all pregnant women. 
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 Table 1. PPH treatment 
 PPH in first 
pregnancy 
 
 
N = 169 
N (%) 
PPH in second 
pregnancy 
(no prior PPH) 
N=105 
N (%) 
PPH in second 
pregnancy 
(prior PPH) 
N=48 
N (%) 
Pharmacological 
therapy* 
   
Oxytocinon bolus/ 
infusion 
  
 Ergometrine 
137 (82.0) 
 
 
129 (77.2) 
 
30 (18.0) 
86 (86.9) 
 
 
85 (85.9) 
 
16 (16.2) 
45 (93.8) 
 
 
44 (91.7)† 
 
8 (16.7) 
Manual removal of 
placenta (among vaginal 
deliveries) 
 
Other uterine 
procedures 
 
Abdominal procedures 
 
 
18 (13.1) 
 
13 (7.7) 
 
4 (2.4) 
 
 
20 (27.8)† 
 
7 (6.7) 
 
1 (1.0) 
 
 
10 (27.8)† 
 
1 (2.1) 
 
0 
Transfusion of blood or 
platelets, fresh frozen 
plasma, cryoprecipitate 
 
13 (7.7) 
 
11 (10.5) 
 
7 (14.5) 
* Details of pharmacological treatment were not available for 8 PPH cases (2 first pregnancies 
and 6 second pregnancies); †denotes p<0.05; Other uterine procedures included exploration 
or other procedures in theatre, intra-uterine balloon and bimanual compression of the uterus; 
Abdominal procedures included exploratory laparotomy, evacuation of CS or pelvic 
haematoma and other procedures to control bleeding. 
 
